NCT06519630

Brief Summary

The goal of the Rehabotics project is the development of a comprehensive rehabilitation system to provide highly individualized treatment of upper limb function in patients with motor disorders due to acquired brain damage (eg stroke) or neurodegenerative disease (eg sclerosis), having as central pillar the integration of robotic systems and support functions. A key part of the proposed system is the development and evaluation of an innovative robotic extraskeletal device that will be applied in the form of a glove to the diseased limb of the neurological patient. The proposed robotic system:

  1. 1.will measure various motor and kinematic parameters of the extremity in order to assess the patient's condition and progress, and
  2. 2.will offer a specialized rehabilitation program (therapeutic exercises, retraining of functional movements and support of daily activities) through an interactive virtual environment provided by the Rehabotics platform.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
Completed

Started Nov 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 4, 2022

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 3, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 3, 2023

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

July 9, 2024

Completed
16 days until next milestone

First Posted

Study publicly available on registry

July 25, 2024

Completed
Last Updated

July 25, 2024

Status Verified

July 1, 2024

Enrollment Period

12 months

First QC Date

July 9, 2024

Last Update Submit

July 19, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Ashworth Scale measured by physiotherapists

    This outcome aims to explore the therapeutic potential of Rehabotics in stroke rehabilitation, demonstrating improved hand motor function through the integration of robotics and Augmented Reality games, measured by Ashworth Scale \[AS\]. The AS is a key instrument for evaluating spasticity in individuals with upper extremity mobility challenges during rehabilitation. This assessment uses a scoring system from 0 to 4, where higher scores denote greater difficulty in finger movement, and lower scores indicate easier finger movement.

    Change from baseline to 5 weeks

  • Box and Block Test score measured by physiotherapists

    This outcome aims to explore the therapeutic potential of Rehabotics in stroke rehabilitation, demonstrating improved hand motor function through the integration of robotics and Augmented Reality games, measured by the Box and Block Test \[BBT\] score. The BBT consists of a wooden box divided into two compartments by a partition and includes 150 blocks. During the BBT administration, the patient is instructed to move as many blocks as possible, one by one, from one compartment to the other within 60 seconds. The higher the number of blocks moved indicate better manual dexterity.

    Change from baseline to 5 weeks

Secondary Outcomes (2)

  • Device Evaluation Satisfaction utilizing questionnaires for patients

    Administered in the 5th week

  • Device Evaluation Satisfaction utilizing questionnaires for physiotherapists

    1 year

Study Arms (2)

Rehabotics Intervention Group

EXPERIMENTAL

Rehabotics Intervention Group received Physiotherapy through the Rehabotics system.

Device: Rehabotics Physiotherapy

Traditional Physiotherapy Group

ACTIVE COMPARATOR

Traditional Physiotherapy Group received Physiotherapy.

Other: Traditional Physiotherapy

Interventions

The intervention will be consisted of sessions for participants in the intervention group which includes a repetition of each of the four Sollerman AR Games named, Wallet, Key, Jar, Screwdriver and one repetition of Balloon Pop. Participants will interact with the AR Box and Block Test (BBT) and the serious games under controlled conditions. A clinician will be present throughout the whole session providing help if participants encounter any difficulties. Following the games, the clinician will initiate a stretching program using the Active Exoskeletal Aid, performing 3 sets of 10 repetitions on the finger flexors of the patient's hand. Each rehabilitation session will last 30 minutes and will be conducted three times a week. Similarly, the traditional physiotherapy training program will be prescribed for the control group and will be consisted of sessions lasting 30 minutes per day, three days per week. Both programs duration will be five weeks.

Rehabotics Intervention Group

Similarly, the hand functional training program prescribed for the control group consisted of sessions lasting 30 minutes per day, three days per week. Both programs lasted for five weeks and were designed by two clinical experts.

Traditional Physiotherapy Group

Eligibility Criteria

Age30 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • stroke pathology,
  • Ashworth Scale ≤ 3,
  • months maximum time since the incident

You may not qualify if:

  • Presence of neurological pathologies that affect hand motion (Parkinson's disease)
  • Musculoskeletal deficits that affect normal finger range of motion (e.g. finger fractures, joint stiffness/pain, arthritis that affect joint motion)
  • Ashworth Scale \> 3,
  • Over 6 months since the incident

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Physioloft, Physiotherapy Center

Athens, Attica, 14562, Greece

Location

MeSH Terms

Conditions

StrokeMuscle Spasticity

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesMuscular DiseasesMusculoskeletal DiseasesMuscle HypertoniaNeuromuscular ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Georgios Papagiannis, PhD

    Physioloft

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 9, 2024

First Posted

July 25, 2024

Study Start

November 4, 2022

Primary Completion

November 3, 2023

Study Completion

November 3, 2023

Last Updated

July 25, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Patient data cannot be provided due to confidentiality and privacy regulations designed to protect individuals' personal information. Upon a formal request, data may be able to be provided anonymized to protect patients' privacy.

Locations